Fundraising Fox

Alphina Therapeutics

New Haven, US · Founded 2021 · Delaware corporation · 3 known investors

alphinatx.com ↗
Biotech

Founders & leadership

BF
Barbara FoxExecutive Officer, Director
CC
Colleen CuffaroDirector
NJ
Nicholas J GalliExecutive Officer, Director
KR
Kevin RakinDirector
MC
Matthew CohenDirector
RB
Ranjit BindraDirector
AA
Anurag AgarwalDirector
KL
Kevin L. RakinExecutive Officer, Director
SC
Stanley ChoyExecutive Officer

Investors · 3

Canaan PartnersStamford · $500K – $20Mvia Colleen Cuffaro · board
Connecticut InnovationsNew Haven · $500K – $2M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

Reported raises · per SEC filings

Form D private placements
▶$153.7KraisedMar 2026 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara FoxExecutive Officer, Director
  • Colleen CuffaroDirector
  • Nicholas J GalliExecutive Officer, Director
  • Kevin RakinDirector
  • Matthew CohenDirector
  • Ranjit BindraDirector
Offering amount
$10M
Amount sold
$153.7K
First sale
Feb 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.9MraisedSep 2021 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Colleen CuffaroExecutive Officer, Director
  • Anurag AgarwalDirector
  • Ranjit BindraExecutive Officer, Director
  • Kevin L. RakinExecutive Officer, Director
  • Stanley ChoyExecutive Officer
Offering amount
$40M
Amount sold
$16.9M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.